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INTRODUCTION
Cardiovascular manifestations in severe falciparum
malaria include mainly hypotension, acute pulmonary
edema, toxic myocarditis and conduction abnormali-
ties1–2. There are also case reports on pericardial tampon-
ade, endomyocardial fibrosis, peripheral gangrene, car-
diomyopathy, shock and cardiac arrhythmias3–11. In ad-
dition to severe falciparum parasitemia and sequestration,
secondary infections, severe anaemia, hypoxia, hyperpyr-
exia, dehydration/fluid overload, metabolic acidosis and
disseminated intravascular coagulation can also contrib-
ute to the cardiovascular problems in malaria7. So far,
only limited data and few case reports are available on
myocardial involvement in falciparum malaria11. We have
been observing severe manifestations also in vivax ma-
laria, therefore, this prospective study was planned to
evaluate cardiovascular manifestations in all types of se-
vere malaria and to study the effect of these on associated
morbidity and mortality.
MATERIAL & METHODS
This prospective study was conducted on patients of
severe malaria who were admitted during July 2010 to
June 2011 in the Department of Medicine, Sardar Patel
Medical College and Associated Group of Hospitals,
Bikaner, India. Informed consent was taken from patient
or patient’s relatives. Ethical clearance was obtained from
the Institutional Ethics Committee, S.P. Medical College,
Bikaner, India.
Inclusion criteria
Only those cases of severe malaria having the asexual
forms of Plasmodium in the blood by smear examination
were included in the study. The diagnosis of severe ma-
laria was done as per WHO 2006 guidelines (Table 1)12.
Exclusion criteria
Patients who refused to give the written consent or
had other concurrent illness or pre-existing diseases like
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ABSTRACT
Background & objectives: Recently, vivax malaria is also presenting as severe malaria causing multiorgan
dysfunction similar to falciparum malaria. The present study was undertaken to evaluate the involvement of
cardiovascular system in severe malaria.
Methods: This is a clinical prospective study conducted on the cases of severe malaria in S.P. Medical College
and PBM Hospital, Bikaner, India. In total, 100 cases (45 males, 55 females; age range 13–75 yr) of severe
malaria (P. vivax 60; P. falciparum 28; and mixed 12) diagnosed by peripheral blood smear examination, rapid
card test and PCR were studied. Evaluation of cardiovascular system was done by clinical examination, chest X-
ray, ECG, high resolution transthoracic echocardiography and estimation of cardiac markers.
Results: In all, 17% cases (9 P. falciparum, 5 P. vivax and 3 mixed) were found to be suffering from cardiovascular
involvement (11% circulatory failure, 7% congestive cardiac failure and 2% pulmonary edema). ECG showed
sinus tachycardia in all the 17 patients, one had atrial ectopic and eight had non-specific ST-T changes. Cardiomegaly
was seen in eight cases and pulmonary edema in two on X-ray chest. Echocardiography was within normal range
but cardiac dimensions were increased in all the 17 cases. Troponin-I and CPK-MB were increased in 14 cases.
Cardiovascular involvement in P. falciparum and mixed infection was associated with high parasite density but P.
vivax infection was associated with relatively low parasite density. Involvement of cardiovascular system was
associated with increased hospital stay (7.67 ± 2.23 vs 6.59 ± 0.87 days; p <0.001) and high mortality (5 died out
of 17 patients). Significant ECG changes and cardiac markers indicate myocardial involvement in severe malaria.
Interpretation & Conclusion: The present study indicates involvement of cardiovascular system in severe malaria
as evidenced by changes in ECG and cardiac markers (Trop 1 and CPK-MB). The present study also highlights
that vivax malaria is no more benign and pathophysiology of vivax malaria should be re-evaluated.
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cardiac diseases, hypertension, diabetes mellitus, COPD,
hepatitis B and C, typhoid fever, HIV, tuberculosis, etc.
were not included in the study.
Diagnostic methods used to detect malaria parasite
The diagnosis of malaria was confirmed by gold stan-
dard method of peripheral blood smear examination of
thick and thin smears by demonstration of asexual form
of Plasmodium. The RDTs were based on detection of
specific Plasmodium spp. Lactate dehydrogenase
(OptiMal test; Diamed AG, Cressier sur Morat, Switzer-
land) and histidine rich protein 2 (Falcivax test; Zephyr
Biomedical Systems, Goa, India). Evidence of Plasmo-
dium spp was further confirmed by PCR. The PCR stud-
ies were targeted against the 18S ribosomal RNA gene of
the parasite and used 1 genus-specific 5′ primer and 2
species-specific 3′ primers in the same reaction mixture.
All the patients were evaluated as per proforma
(CRF). Assessment for cardiovascular involvement was
done by: (a) Thorough clinical examination of cardiovas-
cular system; (b) Chest X-ray: Looking for any evidence
of cardiomegaly, lung field congestion; and (c) Standard
12-lead ECG: Following 14 points were analyzed care-
fully in every ECG: (1) standardization (calibration) and
technical features (including lead placement and artifacts);
(2) rhythm; (3) heart rate; (4) PR interval/AV conduc-
tion; (5) QRS interval; (6) QT/QTc interval; (7) mean
QRS electrical axis; (8) P-waves; (9) QRS voltages; (10)
precordial R-wave progression; (11) abnormal Q waves;
(12) ST segments; (13) T-waves; and (14) U-waves. Se-
rial tracings were recorded in all the patients till discharge.
Cardiac markers: Cardiac marker assay for Troponin–I
and CPK–MB were done in all the patients who presented
with severe malaria. Those patients who initially presented
with increased serum level of these markers, were reevalu-
ated after 21 days of follow up.
High-resolution transthoracic echocardiograms: A com-
plete echocardiographic examination was performed with
usual standard technique using 2.5 and 5.0 MHz trans-
ducers. Echocardiography was done in 95 patients, five
patients who expired on the same day of admission could
not be taken for echocardiography. The examination was
performed with simultaneous registration of a reference
ECG lead. Left parasternal, short axis, apical four-cham-
ber and subcostal views were obtained for proper visual-
ization of all four chambers, great vessels and pericar-
dium. All measurements and calculations were based on
M-mode tracings in three cardiac cycles as per recom-
mendations of the American Society of Echo-cardiogra-
phy. Following parameter were taken—left ventricular
internal dimension-end systolic (LVESD) and end dias-
tolic (LVEDD), interventricular septal thickness (end di-
Table 1. WHO criteria for severe malaria
Manifestation Features
Cerebral malaria Unrousable coma not attributable to any other cause, with a Glasgow Coma Scale score ≤9.
Coma should persist at least for 30 min after a generalized convulsion
Severe anaemia Hematocrit <15% or hemoglobin <50 g/l in the presence of parasite count >10,000/μl
Renal failure Urine output <400 ml/24 h in adults (<12 ml/kg/24 h in children) and a serum creatinine >265
μmol/l (>3 mg/dl) despite adequate volume repletion
Pulmonary edema and acute respiratory The acute lung injury score is calculated on the basis of radiographic densities, severity of
distress syndrome hypoxemia, and positive end-expiratory pressure
Hypoglycemia Whole blood glucose concentration <2.2 mmol/l (<40 mg/dl)
Circulatory collapse (algid malaria) Systolic blood pressure <70 mmHg in patients >5 yr of age (< 50 mmHg in children aged 1–5 yr),
with cold clammy skin or a core-skin temperature difference >10°C
Abnormal bleeding and/or disseminated Spontaneous bleeding from gums, nose, gastrointestinal tract, or laboratory evidence of
intravascular coagulation disseminated intravascular coagulation
Repeated generalized convulsions ≥3 convulsions observed within 24 h
Acidemia/acidosis Arterial pH <7.25 or acidosis (plasma bicarbonate <15 mmol/l)
Macroscopic hemoglobinuria Hemolysis not secondary to glucose-6-phosphate dehydrogenase deficiency
Impaired consciousness Rousable mental condition
Prostration or weakness
Hyperparasitemia >5% parasitized erythrocytes or >250, 000 parasites/μl (in non-immune individuals)
Hyperpyrexia Core body temperature >40°C
Hyperbilirubinemia Total bilirubin >43 μmol/l (>2.5 mg/dl) 287 Nayak et al: Cardiovascular involvement in severe malaria
astolic, DIVST), left ventricular post wall thickness (end
diastolic, DLVPWT), left ventricular ejection fraction
(EF%), peak velocity of early filling phase (Ei), peak ve-
locity of atrial filling phase (Ai) and Ei/Ai ratio.
Other laboratory investigations: CBC including total leu-
kocyte count (TLC), differential leukocyte count (DLC),
hemoglobin (Hb), packed cell volume (PCV), platelet
counts, blood glucose level, blood urea and serum creati-
nine, serum bilirubin, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase,
serum protein, albumin and globulin, and urine examina-
tion were done in all the cases. Dengue serology was also
done to rule out dengue fever. Lumbar puncture and CSF
analysis was done in all the doubtful cases to rule out
other diseases like meningitis and encephalitis. Other rel-
evant diagnostic tests were also done to rule out any other
systemic or cardiac illness.
Statistical analysis: Statistical analysis was done using
MS Excel and SPSS version 11. Data analysis of various
parameters and their comparative statistical significance
was evaluated by applying Chi-square (χ2) test, p-value
of <0.05 was taken as significant. Data analysis of para-
site density was calculated by geometric mean.
RESULTS
A total of 642 cases of malaria (459 P. vivax, 147 P.
falciparum and 36 mixed infections) during July 2010 to
June 2011 were admitted in various wards of Department
of Medicine, out of which 100 consecutive cases of se-
vere malaria (45 males and 55 females; age range 13–75
yr), excluding patients with concurrent illness or pre-ex-
isting diseases, proved by peripheral blood smear exami-
nation, rapid card test and PCR were studied. Out of these
100 cases, 60 were P. vivax (Pv), 28 were P. falciparum
(Pf) and 12 were mixed infections. Flow chart of the study
patients is shown in Fig. 1. Manifestations of severe ma-
laria were severe anaemia (Hb <5 g%) in 27% patients,
followed by hepatitis in 24%, respiratory distress in 23%,
cerebral malaria in 25%, hypoglycemia in 3%, acute re-
nal failure in 11%, abnormal bleeding in 17%, circula-
tory failure in 11%, pulmonary edema in 2% and hemo-
globinuria in 4% patients (Table 2).
Out of these 100 cases of severe malaria, 17 were
found to be suffering from cardiovascular manifestations
11 from circulatory failure (6 Pf, 2 Pv & 3 mixed), seven
from congestive heart failure (3 Pf, 3 Pv & 1 mixed), and
two from pulmonary edema (1 Pf, 1 mixed). Cardiovas-
cular involvement was more commonly found in P.
falciparum malaria as compared to P. vivax or mixed ma-
laria (χ2=13.68; p <0.001) (Table 3).
Most common finding in ECG was sinus tachycardia
which was present in 25% cases of severe malaria (in-
cluding 17 cases with cardiovascular involvement) on Day
1 and in 11% cases on Day 2, however, none of the pa-
tients had sinus tachycardia at the time of discharge. Non-
specific ST-T changes were observed in 8% patients at
the time of admission, 2% cases on Day 2 while none at
the time of discharge. One patient had atrial ectopics. None
of the patients had any abnormality of QRS complex.
M-mode echocardiography showed mean left ven-
tricular end diastolic diameter (LVEDD) of 4.04 ± 0.4
cm (ranging from 3–4.4 cm), left ventricular end systolic
diameter (LVESD) of 2.55 ± 0.44 cm (ranging from 2–3
cm), mean interventricular septal thickness (end diastolic)
was 0.52 ± 0.14 cm (ranging from 0.3–0.7 cm) and left
ventricular post-wall thickness (end diastolic) of 0.46 ±
0.08 cm (ranging from 0.3–0.6 cm). Left ventricular ejec-
tion fraction was 56 ± 1.04% and ranged from 55–65%.
Pulse wave doppler studies showed the mean peak veloc-
ity of early filling phase (Ei), mean peak velocity of atrial
filling phase (Ai), and the mean Ei/Ai ratio were within
normal limits in all the patients. Nine patients had mild
Table 2. Manifestations of severe malaria
Severe manifestations No. of patients (n = 100) Percentage
Severe anaemia 27 (Pv-16; Pf-8; Pv+Pf-3) 27
Hepatitis 24 (Pv-9; Pf-11; Pv+Pf-4) 24
Respiratory distress 21 (Pv-13; Pf-4; Pv+Pf-4) 21
Cerebral dysfunction 25 (Pv-11; Pf-13; Pv+Pf-1) 25
Hypoglycemia 3 (Pf-2; Pv+Pf-1) 3
Acute renal failure 11 (Pv-4; Pf-6; Pv+Pf-1) 11
Bleeding disorder 17 (Pv-8; Pf-4; Pv+Pf-5) 17
Circulatory failure 11 (Pv-2; Pf-8; Pv+Pf-3) 11
Pulmonary edema 2 (Pf-1; Pv+Pf-1) 2
Hemoglobinuria 4 (Pv-1; Pf-3) 4
Multiorgan failure 11 (Pv-2; Pf-8; Pv+Pf-3) 11
Pv—P. vivax malaria (n=60); Pf—P. falciparum malaria (n=28);
Pf+Pv— Mixed malaria (n=12).
Table 3. Distribution of cardiovascular manifestations in
severe malaria
Malaria type Total cases Circulatory Congestive Pulmonary
of cardiovascular failure heart edema
manifestation (n=11) failure (n=2)
(n=17) (n=7)
Severe 9 6 3 1
P. falciparum
(n=60)
Severe P. vivax 52 3 –
(n=28)
Severe mixed 3 3 1 1
(n=12) J Vector Borne Dis 50, December 2013 288
mitral regurgitation, mild tricuspid regurgitation, mild aor-
tic regurgitation and mild pulmonary regurgitation; these
findings were present at the time of admission, on the
day of discharge as well as on Day 21 of follow up. None
of these patients had any valvular thickening. No patient
had any evidence of pericardial effusion and regional or
global hypokinesia. Although various echocardiographic
parameters were within the limit of normal range but there
was a significant difference between patients with or with-
out cardiovascular involvement (Table 4).
Cardiac markers, both Troponin-I and CPK-MB
were increased in 14% cases and were found normal in
3 out of 17 patients who presented with cardiovascular
involvement (Table 5). Out of 17 patients, 11 of them
developed circulatory failure presented with tachycardia,
tachypnoea, decreased urine output, feeble pulses and hy-
potension. Multiorgan failure was present in all cases.
X-ray chest showed cardiomegaly and bilateral basal
lung infiltrate in two cases. ECG showed sinus tachycar-
dia in all and non-specific ST-T changes in four cases.
Echocardiography did not show any significant valvular
thickening, four patients showed mild regurgitant lesions
at the time of admission which persisted even after 21
days of follow up. Circulatory failure was found more
commonly in severe falciparum infection than vivax or
Table 5. Cardiac markers in patients of severe malaria with cardiovascular system involvement (n = 17)
Patients S.No. 1 2 4 11 18 21 22 26 32 34 40 56 60 63 68 88 90
Type of malaria Pv M Pf Pv Pf M Pv Pf M Pf Pf Pv Pv Pf Pf Pf Pf
Trop-I (μg/l) 1.1 1.5 0.9 1.23 <0.01 1.96 <0.01 1.45 1.23 2.1 1.73 1.89 <0.01 0.78 1.39 1.95 1.63
CPK-MB(IU/dl) 6.2 7.4 5.9 6.7 0 9 0 6.2 7.3 9.4 8.1 6.5 0 7.7 8.4 9.2 8.9
Pv— P. vivax malaria; Pf— P. falciparum malaria; M— Mixed malaria.
Table 4. Echocardiographic parameters in severe malaria
Echocardiographic With Without χ2 p-value
parameter cardiac cardiac
(mean ± SD) involvement involvement
(n = 17) (n = 83)
LVEDD (cm) 4.04 ± 0.4 3.76 ± 0.43 3.84 0.0001
LVESD (cm) 2.55 ± 0.44 2.45 ± 0.34 5.18 0.0001
DIVST (cm) 0.52 ± 0.14 0.53 ± 0.10 1.48 0.5
DLVPWT (cm) 0.46 ± 0.08 0.49 ± 0.09 2.66 0.01
EF (%) 56.34 ± 1.04 59.11 ± 1.12 2.82 0.01
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mixed infection. Out of total 11 patients of circulatory
failure, five patients expired (mortality = 45.45%).
Congestive heart failure was observed in seven cases.
All of them had Hb ≤5 g% and presented with dyspnoea,
lethargy, pallor, tachypnoea, tachycardia, a gallop rhythm
and tender hepatomegaly. These patients were treated with
diuretics and slow correction of anaemia by packed cell
transfusion. All the patients recovered except one who
was in circulatory failure. Cardiomegaly was found in all
the patients with congestive heart failure. ECG showed
sinus tachycardia in all and non-specific ST-T changes
were found in four patients. Echocardiography showed
increased cardiac dimension with normal systolic and di-
astolic functions.
Two cases had pulmonary edema presented with dys-
pnoea, tachypnea, hypotension, bilateral coarse crepts and
decreased urine output. Both patients had multiorgan dys-
function. Chest X-ray showed increased vascular mark-
ing including thickening of the interlobular septa and bi-
lateral lung infiltrate. ECG showed sinus tachycardia in
both patients. Echocardiography did not show any sig-
nificant valvular lesion although one patient had mild MR,
TR and AR at admission.
The parasite density (PD) was higher in patients with
cardiovascular involvement (geometric mean PD =
14563.68/μl) than those without cardiovascular involve-
ment (geometric mean PD = 8190.65/μl). In patients with
cardiovascular involvement, parasite density was highest
in those who were suffering from P. falciparum infection
(geometric mean PD = 27439.95/μl) followed by mixed
malaria (geometric mean PD = 21253.17/μl) while in P.
vivax malaria geometric mean parasite density was
3711.74/μl (p <0.001). This shows that severe malaria
(including with cardiovascular involvement) due to P.
vivax infection was associated with relatively lower para-
site density (Table 6).
Cardiovascular manifestations were associated with
high mortality rate. Case fatality rate in circulatory fail-
ure was 45.45%, in pulmonary edema was 100%, and in
congestive heart failure was 14%. Other prognostic indi-
cators were multi-organ failure, severe anaemia, acute re-
nal failure and respiratory distress (Table 7).
DISCUSSION
Reports on cardiovascular manifestations in malaria
are very few and most of them are case reports in
falciparum malaria1–11. Present study was conducted to
see the prevalence and type of cardiovascular manifesta-
tions in severe malaria using 12 lead ECG monitoring,
radiological chest examination, cardiac markers and high-
resolution transthoracic echocardiogram.
The present study showed cardiovascular manifesta-
tions in 17% of the cases and 11% had circulatory fail-
ure. Myocardial function is generally well-preserved in
severe falciparum malaria9, 13–14. The cardiac index may
be elevated with low peripheral vascular resistance and
low to normal ventricular filling pressures. Hypovolumia
(due to reduced fluid intake, high grade fever, sweating,
vomiting and diarrhoea) also may contribute to the re-
duced pressures. Orthostatic hypotension is common. Sep-
ticemia, metabolic acidosis and hypoxia may result in a
drop in cardiac index15. The pathophysiology of myocar-
dial injury in falciparum malaria remains obscure. Is-
chemia, acidosis, toxic effects of substances like falcipar-
um glycosyl-phosphatidyl-inositol, or Plasmodium-
triggered mechanisms like apoptosis may be responsible
for myocardial damage7, 9. In our study, patients with cir-
culatory failure presented with tachycardia, tachypnoea,
decreased urine output, feeble pulses and hypotension,
patients who died had a greater number of these signs
than survivors. These patients had history of vomiting in
Table 6. Parasite density in severe malaria patients (n = 100) (with and without cardiovascular involvement)
Cardiovascular involvement (n = 17) No cardiovascular involvement (n = 83)
Type of malaria P. falciparum P. vivax Mixed Total P. falciparum P. vivax Mixed Total
No. of cases 9 5 3 17 19 55 9 83
Range of parasite density 1800–56000 800–8600 8000–40000 800–56000 2000–40000 400–40000 1200–28000 400–40000
Geometric mean 27439.95 3711.74 21253.17 14563.68 9190.03 5885.70 4802.91 8190.65
Table 7. Severe manifestations and associated mortality in
severe malaria
Severe manifestations Prevalence Mortality χ2 p-value
(n=100) No. (%)
Severe anaemia 27 3 (11.11) 13.68 0.0002
Cerebral dysfunction 25 4 (16) 5.82 0.015
Hepatitis 24 5 (20.83) 13.07 0.0003
Acute renal failure 11 5 (45.45) 1.7 0.192
Respiratory distress 21 5 (23.80) 24.97 0.0001
Circulatory failure 11 5 (45.45) 13.89 0.0001
MODS 11 5 (45.45) 34.58 0.0001
Pulmonary edema 2 2 (100) – – J Vector Borne Dis 50, December 2013 290
46%, and abnormal bleeding in 13% (epistaxis in 12%,
and hemetemesis in one case). High grade fever, exces-
sive sweating and inadequate fluid intake may also have
contributed to dehydration seen in some patients.
Multiorgan failure was present in all the cases of circula-
tory failure, with anaemia in all the cases (severe anaemia
in 4; moderate anaemia in 5; and mild anaemia in 2 pa-
tients), hepatitis in 8 (72.72%), renal failure in 8 (72.72%),
cerebral dysfunction in 5 (45.45%), respiratory distress
in 8 (72.72%), and pulmonary edema in 2 (18.18%) cases
suggesting multiorgan pathogenesis of circulatory fail-
ure. Myocarditis may have a role in circulatory failure
seen in our cases as shown by raised cardiac markers13.
Mortality with circulatory failure (45.45% in our
study) was higher that was similar to other studies, the
majority of patients with circulatory collapse died within
24–48 h after admission emphasizing the need for triage
and early treatment6, 8.
The present study showed congestive heart failure in
seven cases, all of them had Hb ≤5 g% and cardiome-
galy. Although cardiac enlargement is usually seen in
chronic anaemia, but, if it is present in acute anaemia it is
a result of presence of other cardiovascular disease, may
be acute malarial myocarditis in our patients16.
We observed two cases of pulmonary edema. Both
patients had multi-organ dysfunction such as anaemia,
respiratory distress, renal failure and cerebral dysfunc-
tion and both of them died (mortality 100%). Acute pul-
monary edema is a grave and usually fatal complication
of severe falciparum malaria with >50% mortality. Pul-
monary edema develops later compared to other compli-
cations and it may even appear several days after treat-
ment for malaria, when the patient is otherwise improving
with a reduction in peripheral parasitaemia. The mecha-
nism of pulmonary edema is not clearly understood. It
has a close resemblance to adult respiratory distress syn-
drome. While over-hydration may be the cause in some
cases of pulmonary edema, it can also develop in patients
with normal capillary wedge pressures. Such cases may
be due to increased permeability of pulmonary capillar-
ies, sequestration of red cells and clogging of pulmonary
microcirculation and disseminated intravascular
coagulation5. Pulmonary edema is more common in pa-
tients with hyperparasitaemia, renal failure and it is com-
monly associated with hypoglycemia and metabolic aci-
dosis.
All the patients with cardiovascular involvement who
revealed mild regurgitant lesions were mild to severely
anemic. Similar valvular lesions were also present in five
patients of severe malaria in whom no other abnormality
of cardiovascular system was found but they were hav-
ing severe anaemia. Repeat 2D-ECHO after 21 days fol-
low up in such patients showed similar findings. As we
did not find any abnormality of anatomy of valvular cusps,
regurgitant lesions can be explained by anaemia present
in such cases, although possibility of malarial cause can
not be ruled out, large-scale study and long-term follow
up of such patients may be required.
ECG changes seen in our study may indicate early
myocardium involvement because electrophysiology of
cardiac myocytes alters before changes could be seen on
echocardiography. Although it can also be explained by
the presence of severe anaemia, these changes can also
be due to a variety of other factors like hyperventilation,
anxiety, body position, food, neurogenic influences, tem-
perature, electrolyte imbalance, allergic reactions. Simi-
larly, previous studies have shown a variety of abnor-
mality on ECG but these bear uncertain correlation with
clinical and functional status of heart17.
Mohapatra et al18 showed involvement of the myo-
cardium in cerebral malaria, it can cause myocardial in-
jury, reversible global hypokinesia similar to myocardial
stunning and diffuse myocardial necrosis as evidenced
by raised Troponin-T, echo, and autopsy.
Thus, our study concludes that there is involvement
of cardiovascular system in severe malaria as shown by
changes in ECG and cardiac markers (Trop. I and CPK-
MB) indicating myocardial involvement and it is associ-
ated with increased morbidity and mortality. Limitations
of our study were that: (i) we could not do immediate bed
side echocardiography as this facility was not available,
patients had to be shifted to echo-room for the invest-
igation; and (ii) we did only 21 days follow up. Further
studies including bed side echocardiography, Holter
monitoring and long-term follow up may put more in-
sight on cardiovascular system involvement in malaria.
Our study also showed that severe vivax malaria (in-
cluding with cardiovascular involvement) is associated
with relatively lower parasite density as compared to
falciparum and mixed infection. This has been first re-
ported by us and it shows that vivax malaria is no more
benign and pathophysiology of vivax malaria should be
re-evaluated.
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